Old National Bancorp’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-4,155
Closed -$224K 574
2020
Q4
$224K Buy
+4,155
New +$188K 0.01% 518
2020
Q1
Sell
-7,293
Closed -$213K 537
2019
Q4
$213K Buy
+7,293
New +$174K 0.01% 517
2019
Q2
Sell
-11,116
Closed -$227K 577
2019
Q1
$227K Sell
11,116
-1,284
-10% -$22.3K 0.01% 510
2018
Q4
$156K Sell
12,400
-8,398
-40% -$125K 0.01% 545
2018
Q3
$319K Sell
20,798
-1,588
-7% -$21.9K 0.02% 480
2018
Q2
$293K Sell
22,386
-6,378
-22% -$70.2K 0.02% 493
2018
Q1
$235K Buy
28,764
+4,615
+19% +$37.4K 0.01% 562
2017
Q4
$214K Buy
24,149
+2,435
+11% +$22.5K 0.01% 588
2017
Q3
$242K Buy
21,714
+6,004
+38% +$58.4K 0.01% 563
2017
Q2
$141K Buy
+15,710
New +$125K 0.01% 601

Other funds holding NEO

Old National Bancorp's NEO Position: Q1 2021 in Review

Old National Bancorp sold out of NeoGenomics (NEO) in Q1 2021, closing a stake of 4,155 shares — an estimated $224K sold.

Old National Bancorp first reported a position in NEO in Q2 2017 and held it in 10 quarters. The position peaked at $319K in Q3 2018. 332 funds tracked by Wall St. Rank hold NEO as of Q1 2021.

  • Old National Bancorp reported no remaining NeoGenomics position as of Q1 2021 after selling out during the quarter.
  • Old National Bancorp sold 4,155 NeoGenomics shares in Q1 2021, an estimated $224K.
  • Old National Bancorp first reported a position in NeoGenomics in Q2 2017 and held it in 10 quarters.
  • Old National Bancorp's NeoGenomics position peaked at $319K in Q3 2018.
  • 332 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2021.

Based on Old National Bancorp's 13F filing for Q1 2021, filed 21 Apr 2021.